Navigation Links
Ground Breaking Molecular Diagnostics Business Appoints New CEO
Date:2/7/2010

D3 Technologies Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS), today announced that it has appointed David Burns as its new Chief Executive Officer. He will lead the Company towards the international launch of its first in-vitro diagnostic (IVD) products, with the aim to establish D3 Technologies as a global player in the field of molecular diagnostics for human infectious diseases.

Glasgow, Scotland (PRWEB) -- D3 Technologies Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS), today announced that it has appointed David Burns as its new Chief Executive Officer. He will lead the Company towards the international launch of its first in-vitro diagnostic (IVD) products, with the aim to establish D3 Technologies as a global player in the field of molecular diagnostics for human infectious diseases. Mr Burns has over 20 years of commercial life sciences experience, most recently as VP of Sales & Marketing with Cyntellect Inc, and before that as Head of Strategic Growth with GE Healthcare Life Sciences.

The Company’s current CEO, Professor Ewen Smith, is standing down to focus on the technical development of the exciting portfolio of diagnostics products that D3 Technologies has targeted for the next few years. Speaking about the new appointment he said, “I am delighted to welcome David to the Company. We already have a strong multi-disciplinary technical team and with his proven leadership skills, international experience of the clinical molecular diagnostics market and excellent track record in business development, the future is very bright for D3 Technologies.”

Mr Burns has gained extensive knowledge of sales, marketing and business development within the life sciences sector. Prior to GE Healthcare he also held senior roles within Amersham Biosciences, was CEO at Imaging Research Inc before its acquisition by Amersham, and VP of Business Development at BioSignal Packard Inc. “I am very excited by this new challenge,” said Mr Burns. “D3 Technologies has a tremendous future and I am looking forward to helping the team deliver world-class DNA-based diagnostic tests to detect diseases, or the genetic predisposition to diseases.”    

About D3 Technologies Ltd
D3 Technologies Ltd is a pioneer in trace level detection technologies based on the exploitation of Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS). By combining world-class nanometrology with unique Klarite® substrate technology, it serves a diverse range of fields including medical diagnostics, analytical applications, security and bio-defence, and forensic science. The Company is based in Glasgow, Scotland, and is part of the Renishaw Group, a world-leader in engineering, medical device and Raman spectroscopy technologies. Further information is available at www.d3diagnostics.com.

###

Read the full story at http://www.prweb.com/releases/CEO_D3_Technologies/molecular_diagnostics/prweb3560654.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Fairbank Farms Voluntarily Recalls 85% Ground Round Beef Patties Sold Fresh from Shaws Due to Possible Health Risk
2. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
3. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
4. International Law Enforcement Operation Targets Underground Manufacture of Anabolic Steroids
5. Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs
6. UH to Break Ground for New Ahuja Medical Center
7. First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E. Coli Contaminated Ground Beef
8. E. Coli Registry Expanded for Victims of E. Coli Poisoning from Cargill Ground Beef
9. Ground Zero Pharmaceuticals Announces Expansion of Regulatory Consulting Services to South Africa
10. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
11. The politics of the playground: lack of athletic skill often means loneliness and peer rejection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ground Breaking Molecular Diagnostics Business Appoints New CEO
(Date:6/20/2017)... ... ... With certifications and experience that puts them at the top of the ... are currently accepting new patients at their practice for these custom clear aligners. These ... is why they offer the latest in modern dental techniques to ensure that all ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage (UA), a multi-channel retailer ... designed to create tailored looks and athleisure-inspired outfits. UA Flex fabric is breathable, wrinkle ... twill. , With trendy looks hitting the medical community, UA Flex is for the ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... bedside, would like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN ... whose insight and expertise in healthcare will provide invaluable direction for the company,” ...
(Date:6/19/2017)... New York, NY (PRWEB) , ... June 19, 2017 , ... ... and this year, it’s going to be a humdinger. A warm winter and wet ... devour summer wedding guests. “No one wants to be swatting away pesky mosquitoes when ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... nonprofit community, announces the general availability of several new and improved features to ... integration with United Way iGuide data in support of national campaigns. The ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the ... Tuesday, June 13, 2017, in Rancho Palos Verdes, ... chief executive officer, is scheduled to present at 3:20 p.m. ... accessed at http://ir.hill-rom.com/events.cfm . A recorded replay will be ... September 13, 2017. ...
(Date:5/29/2017)... May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... which enables the functional selection of stem cells, today ... the first quarter ended March 31 st , 2017. ... accomplishments in the first quarter of 2017," said Dr. ... we announced the treatment of the first blood cancer ...
(Date:5/26/2017)... BARBARA, Calif. , May 25, 2017  In ... United States , Direct Relief is working with ... overdose-reversing Naloxone available at no cost to community health ... other nonprofit providers nationwide. "Pfizer has ... access to medicines and ensuring patient safety through educational ...
Breaking Medicine Technology: